Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: RNA-seq analysis of prostate cancer cell line treated with SCFAs

PROVIDER: PRJNA881399 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21613848_1.fastq.gz	Fastqsanger.gz
	SRR21613848_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Project description:RNA-Seq of prostate cancer cell line 22RV1

| PRJNA544264 | ENA

Genome wide mapping of PSF binding sites in prostate cancer cells

Project description:Prostate cancer is the most common cancer in men and AR downstream signalings promote prostate cancer cell proliferation. We identified androgen-regulated long non-coding RNA, CTBP1-AS, located in the antisese region of CTBP1 gene. CTBP1-AS activate AR signaling by epigenetically repress AR-associated cofactors such as CTBP1 by interactign with RNA-binding protein PSF and recruiting HDAC complex to the target promoters. In order investigated the PSF target genes, we performed ChIP-seq analysis of PSF binding sites in prostate cancer cell line, LNCaP cells. We identified androgen dependent PSF binding regions in prostate cancer cell genome. We observed PSF bindings around the promoters of androgen repressed genes such as CTBP1, p53 and SMAD3. ChIP-sequence analysis of PSF binding sites in prostate cancer cells

2014-01-01 | E-GEOD-45124 | biostudies-arrayexpress

Project description:Prostate cancer cell line RNA sequencing

| PRJNA1149944 | ENA

Homo sapiens

Project description:RNA-seq analysis of BAP18 knockdown in prostate cancer cell line 22Rv1

| PRJNA320835 | ENA

RNA-Seq analysis of prostate cancer cell line PC-3 treated with siRNA control (siCont) and siELL2

Project description:RNA-Seq analysis of prostate cancer cell line PC-3 treated with siRNA control (siCont) and siELL2

| PRJNA554330 | ENA

Genome wide analysis of androgen-regulated miRNAs

Project description:Prostate cancer is the most common cancer in men and AR downstream signalings promote prostate cancer cell proliferation. To investigate the AR signaling, we performed short RNA sequence analysis in AR positive prostate cancer cell line, LNCaP. In addition, we used hormone-refractory prostate cancer model cells, Bicalutamide-resistant (BicR) to explore the differences of androgen signaling in prostate cancer progression.

2015-09-01 | GSE66035 | GEO

3prime RNA-seq of human prostate cancer cell line DU-145 treated with Senexin A

Project description:3prime RNA-seq of human prostate cancer cell line DU-145 treated with Senexin A

| PRJEB16139 | ENA

RNA-seq profiling of 22Rv1 prostate cancer cells exposed to repeated DNA damage for 6 weeks.

Project description:RNA-seq profiling of 22Rv1 prostate cancer cell line either untreated, 6 weeks in culture (age matched) or treated daily for 6 weeks with 1 microgram per ml phleomycin to induce DNA damage (n=3 per sample).

2022-07-18 | GSE208190 | GEO

Investigation of androgen-regulated lncRNAs in prostate cancer cells

Project description:Prostate cancer is the most common cancer in men and androgen receptor (AR) downstream signalings promote prostate cancer cell proliferation. To investigate the AR signaling, we performed directional RNA sequence analysis in AR positive prostate cancer cell line, LNCaP and VCaP. Using Noncode and GENCODE data sets. We identified androgen-regulated long non-coding RNAs (lncRNAs) in prostate cancer cells.

2016-08-01 | GSE82223 | GEO

Genome wide mapping of PSF binding sites in prostate cancer cells

2014-01-01 | GSE45124 | GEO